Mesoblast raises $59.8M via NASDAQ listing

Mesoblast Ltd. (ASX:MSB; NASDAQ:MESO) gained $0.11 to $8.11 after it raised $59.8 million through the sale of 7.5 million ADSs at $8 in its first U.S. listing. Each ADS is worth five ordinary shares. Underwriters were JPMorgan, Credit Suisse, Maxim and Ladenburg Thalmann.

Mesoblast said in a Nov. 6 regulatory filing that it hoped to sell 5.7 million ADSs at an assumed ADS price of $12.10. ...